Redefining MGUS to better predict progression to active disease

Predicting progression of MGUS/SMMПодробнее

Insights into the mechanisms leading to progression from MGUS and SMM to multiple myelomaПодробнее

Predicting SM/MGUS progressionПодробнее

Identifying high-risk patients with SMM & MGUS to prevent progression to active myelomaПодробнее

MGUS: predicting the risk of progressionПодробнее

Using flow cytometry to detect abnormal plasma cells in MGUS & predict disease progressionПодробнее

Genomic analysis of patients with MGUS who progress to myeloma versus those who do notПодробнее

Why do Waldenström’s and Myeloma Change from MGUS to Active Disease?Подробнее

Defining precursor conditions in multiple myeloma & strategies to better predict risk of progressionПодробнее

What is MGUS?Подробнее

Risk Stratification for MGUS | Dr. S. Vincent Rajkumar | Oncology BrothersПодробнее

The Role of Lifestyle on MGUS Progression | Betsy O’Donnell, MD | ASCO 2023Подробнее

Improving risk stratification models for patients with MGUS and smoldering myelomaПодробнее

Should individuals diagnosed with MGUS or SMM be receiving bisphosphonates? #myelomaПодробнее

Determining the prevalence of MGUS & deciphering the mechanisms of disease progressionПодробнее

How to manage low-risk MGUS | Part - 1 - Dr. S. Vincent Rajkumar - #OncologyBrothers #cancer #shortsПодробнее

Blood screening for MGUS: preventing progression with PROMISEПодробнее

Understanding MGUS and SMM Progression - Irene Ghobrial, MD | MCRT Webcast September 26 (2/3)Подробнее

The importance of better identifying individuals with MGUS & the possibility of treating precursorsПодробнее